Tuesday, December 12, 2017
 
 
Company News: Page (1) of 1 - 03/06/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Novartis' Cosentyx® shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
- 94% of patients regained their PASI 75 response and the majority re-achieved their PASI 90 or 100 response after 16 weeks of Cosentyx 300 mg retreatment(1)- Patients may need to pause treatment due ...
(March 06, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA,Medicine,Disease,healthcare,Surgery,Medication,Vitamins/Nutrition,Womens Health,Physician,Nurse,Health Technologist,Science,Internet Technology,Medical,Other,Medical Professionals,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines